Below are the most recent publications written about "Peripheral Arterial Disease" by people in Profiles.
-
Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA. Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study. J Comp Eff Res. 2025 01; 14(1):e240055.
-
Brodmann M, Gray WA, Schneider PA, Kurzmann-Guetl K, Schweiger L, Zeller T, Thieme M, Kilaru S, Bachinsky WB, Feldman RL, Holden A, Varcoe RL, Lansky AJ, Rosenfield K. Editor's Choice - Results of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: 24 Month Outcomes of the Randomised TRANSCEND Study. Eur J Vasc Endovasc Surg. 2025 Mar; 69(3):452-462.
-
Gray WA, Soga Y, Fujihara M, Iida O, Babaev A, Kawasaki D, Zeller T, O'Connor D, Jaff MR, Chavez AM, M?ller-H?lsbeck S. Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value. J Comp Eff Res. 2024 06; 13(6):e240025.
-
Parikh SA, Schneider PA, Mullin CM, Rogers T, Gray WA. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis. Lancet. 2023 11 18; 402(10415):1848-1856.
-
Weinstein EJ, Stephens-Shields AJ, Newcomb CW, Silibovsky R, Nelson CL, O'Donnell JA, Glaser LJ, Hsieh E, Hanberg JS, Tate JP, Akg?n KM, King JT, Lo Re V. Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee Arthroplasty. JAMA Netw Open. 2023 10 02; 6(10):e2340457.
-
Brodmann M, Werner M, Sood A, Gray WA. Treating post-angioplasty dissection in the femoropopliteal arteries using the tack endovascular system: Tack optimized balloon angioplasty II 24-month results. Vascular. 2024 Aug; 32(4):850-857.
-
Gray WA, Cardenas J, Teigen CL. Evaluation of safety and efficacy of the S.M.A.R.T.? Flex Vascular Stent System (OPEN study). Catheter Cardiovasc Interv. 2022 11; 100(6):1078-1087.
-
Aru RG, Tyagi SC. Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations. Semin Vasc Surg. 2022 Jun; 35(2):180-189.
-
Kobo O, Saada M, Laanmets P, Karageorgiev D, Routledge H, Crowley J, Baello P, Requena JB, Span? F, Perez L, Jimenez Mazuecos JM, Mamas MA, Roguin A. Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry. Atherosclerosis. 2022 03; 344:71-77.
-
Gray WA, Griffiths RI, Elroy PWM, Amorosi SL, McGovern AM, Jaff MR, Akehurst R, M?ller-H?lsbeck S. Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention. J Med Econ. 2022 Jan-Dec; 25(1):880-887.